Esperanza Lavilla-Rubira Selected Research

Transplantation

1/2021

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esperanza Lavilla-Rubira Research Topics

Disease

3	COVID-19 01/2024 - 01/2023
3	Neoplasms (Cancer) 10/2023 - 03/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 01/2023
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023 - 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Leukemia 01/2021

Drug/Important Bio-Agent (IBA)

1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024
1	Antiviral Agents (Antivirals)IBA 10/2023
1	molnupiravirIBA 10/2023
1	nirmatrelvir and ritonavir drug combinationIBA 10/2023
1	tixagevimabIBA 01/2023
1	cilgavimabIBA 01/2023

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 05/2023 - 03/2020
1	Radiotherapy 01/2022
1	Therapeutics 01/2022
1	Stem Cell Transplantation 01/2021
1	Transplantation 01/2021